Name
Servier Pharmaceuticals
What We Do
Servier Pharmaceuticals is a commercial-stage pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier Pharmaceuticals is committed to building a robust portfolio, starting with oncology, with future growth driven by innovation in other areas of unmet medical need, leveraging Servier’s global portfolio and seeking acquisitions, licensing deals and partnerships.
Website
https://www.servier.us/
Address
200 Pier Four Blvd
Boston, MA 02210
United States
LinkedIn
Twitter

Listings

Relevance
Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated AML and IDH1-mutated CCA
Servier Pharmaceuticals
Servier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual Grade 2 IDH-Mutant Diffuse Glioma
Servier Pharmaceuticals